By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Specialty Pharmacy87.54M59.37%
Patient Services59.09M40.08%
Clinical trials & other813K0.55%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States502.73M100.00%